Encompass Health (EHC) Expected to Announce Quarterly Earnings on Thursday

Encompass Health (NYSE:EHC - Get Free Report) will likely be releasing its earnings data after the market closes on Thursday, February 6th. Analysts expect Encompass Health to post earnings of $1.05 per share and revenue of $1.38 billion for the quarter. Individual interested in registering for the company's earnings conference call can do so using this link.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. Encompass Health's revenue for the quarter was up 11.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.86 EPS. On average, analysts expect Encompass Health to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Encompass Health Stock Up 2.9 %

EHC stock traded up $2.81 during mid-day trading on Thursday, hitting $98.38. 644,583 shares of the company were exchanged, compared to its average volume of 588,441. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health has a twelve month low of $70.83 and a twelve month high of $104.55. The firm has a fifty day simple moving average of $96.58 and a 200 day simple moving average of $94.58. The company has a market capitalization of $9.91 billion, a PE ratio of 23.76, a price-to-earnings-growth ratio of 1.13 and a beta of 0.89.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on EHC shares. Truist Financial reiterated a "buy" rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. KeyCorp increased their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a report on Tuesday, October 29th. Barclays lifted their price target on shares of Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a report on Tuesday, October 29th. Finally, Royal Bank of Canada raised their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a report on Wednesday, October 30th. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Buy" and a consensus target price of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.